Push launch MHRA approves GLP –one receptor agonist semaglutide to reduce danger of significant heart troubles in obese or overweight Grown ups Semaglutide is the primary weight-loss drug accredited in britain to be a preventative procedure for anyone with set up heart problemsMany current research have demonstrated us that semaglutide is a highl